4D Medical dubs the FDA’s approval of its lung imaging tool as an historic moment –…
Continue ReadingTag: FDA
Clinical Reflections on the SSRI and Pregnancy FDA Panel
BRAIN TRUST: CONVERSATIONS IN PSYCHOPHARMACOLOGY -Series Editor Joseph F. Goldberg, MD Joseph F. Goldberg, MD: Hello…
Continue Reading
Where The FDA And EMA Stand On Digital Endpoints
By Anita Burrell, principal, Anita Burrell Consulting LLC Digital biomarkers are quickly and quietly becoming a…
Continue Reading
FDA weighs warning labels on antidepressants for pregnancy despite safety
The Food and Drug Administration is considering adding warning labels to antidepressants for women who are…
Continue Reading
How FDA panelists casting doubt on antidepressant use during pregnancy could lead to devastating outcomes for mothers
At a meeting held by the Food and Drug Administration on July 21, 2025, a panel…
Continue Reading
Antidepressants in pregnancy: Doctors decry ‘misinformation’ after FDA panel meets : Shots
Doctors are criticizing a recent expert panel organized by the U.S. Food and Drug Administration that…
Continue Reading
FDA Panel Casts Doubt on Safety of SSRI Use in Pregnancy
On Monday, July 21, a 10-member panel headed by Marty Makary, MD, MPH, commissioner of the…
Continue Reading
FDA panel on SSRI antidepressants in pregnancy raises alarms
The U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a…
Continue Reading
FDA panel weighs risks, benefits of antidepressants during pregnancy
Add topic to email alerts Receive an email when new articles…
Continue Reading
FDA panel promotes misinformation about antidepressants during pregnancy, psychiatrists say
A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted…
Continue Reading